Tuberculin Shortage
Last Updated: March 6, 2020
Status: Resolved
Reason for the Shortage
-
- Par has Aplisol available.
- Sanofi Pasteur has Tubersol available.
Available Products
-
- Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 42023-0104-01
- Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 42023-0104-05
- Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 49281-0752-21
- Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 49281-0752-22
Estimated Resupply Dates
-
- All presentations are available.
Implications for Patient Care
-
- CDC has additional information regarding the anticipated tuberculin shortage as well as management strategies on their website at https://emergency.cdc.gov/han/han00420.asp. The supply interruption is estimated to begin in June 2019 and continue for approximately 3 to 10 months.
Updated
Updated March 6, 2020 by Anthony Trovato, PharmD, BCPS. Created June 12, 2019 by Megan Dryer, PharmD. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.